Steffen Weikert

4.8k citations

81 papers · 2.9k indexed · 1 hit paper · h-index 28

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Pulmonary and Respiratory Medicine top 2%
- Renal cell carcinoma treatment

Papers in

Cancer Research 20
- Cancer Genomics and Diagnostics 12
Pulmonary and Respiratory Medicine 42
- Renal cell carcinoma treatment 25
- Prostate Cancer Diagnosis and Treatment 11

Co-authors: Kurt Miller Börje Ljungberg Jung Eun Lee Lambertus A. Kiemeney Steven C. Campbell Didier Jacqmin Mark Schrader Hans Krause
Journals: Journal of Clinical Oncology (9 papers)World Journal of Urology (6 papers)Journal of Cancer Research and Clinical Oncology (5 papers)European Urology (4 papers)International Journal of Cancer (4 papers)
Partner nations: Germany United States Austria

In The Last Decade

Steffen Weikert

77 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

The Epidemiology of Renal Cell Carcinoma 2011 · 763 citations

Peers

Countries citing papers authored by Steffen Weikert

Since Specialization

Citations

This map shows the geographic impact of Steffen Weikert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Weikert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Weikert more than expected).

Fields of papers citing papers by Steffen Weikert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Weikert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Weikert. The network helps show where Steffen Weikert may publish in the future.

Co-authors

The 25 scholars most cited alongside Steffen Weikert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steffen Weikert Line = papers co-authored together Steffen Weikert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Stent for Every Stone? Prestenting Habits and Outcomes from a German Multicenter Prospective Study on the Benchmarks of Ureteroroscopic Stone Treatment (BUSTER) Urologia Internationalis ·Josef Markoš, Steffen Weikert, Amel Korti, Martin Schostak, Steffen Lebentrau	2020	10
2	Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study BMC Cancer ·Lothar Bergmann, M. Walker, Christian Doehn, Thomas Steiner, Peter J. Goebell, Manfred Kindler, Edwin Herrmann, Jan Janßen, Steffen Weikert, E. Schäffer, Brian Krahl, Michael Albrecht, Michael Staehler	2015	22
3	Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin BMC Medical Informatics and Decision Making ·D. Baumunk, Jana-Lea Davidson, Rio Tanabashi, Hui Xue, Carsten Kempkensteffen, Ursula Steiner, Steffen Weikert, Matti Supponen, Mark Schrader, Stefan Höcht, Thomas Wiegel, Kurt Miller, Martin Schostak	2013	7
4	miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome Journal of Molecular Diagnostics ·Rodolfo Arruda Leite de Barros, Hellmuth‐Alexander Meyer, Monika Jung, Paola Longhi, Hans‐Joachim Mollenkopf, Ina Wagner, Kurt Miller, Ergin Kilic, Andreas Erbersdobler, Steffen Weikert, Klaus Jung	2013	126
5	Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer Oncology Reports ·Angelika Tölle, Monika Jung, EC Castañeda, Ergin Kilic, Klaus Jung, Steffen Weikert	2013	73
6	Categories of response to first line vascular endothelial growth factor receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma European Journal of Cancer ·Jonas Busch, Christoph Seidel, J D Obayemi, 哲男中島, Robert W. Peters, Frank Friedersdorff, Ahmed Magheli, Kurt Miller, Viktor Grünwald, Steffen Weikert	2013	18
7	Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas International Journal of Biological Sciences ·Zofia Wotschofsky, 中合, Hellmuth‐Alexander Meyer, Monika Jung, Ina Wagner, Alexander C. Disch, K.-D. Schaser, I. Melcher, Ergin Kilic, Jonas Busch, Steffen Weikert, Kurt Miller, Andreas Erbersdobler, Hans‐Joachim Mollenkopf, Klaus Jung	2012	76
8	Reference miRNAs for miRNAome Analysis of Urothelial Carcinomas PLoS ONE ·Rodolfo Arruda Leite de Barros, Hellmuth‐Alexander Meyer, Monika Jung, Hans‐Joachim Mollenkopf, Ina Wagner, Kurt Miller, Ergin Kilic, Andreas Erbersdobler, Steffen Weikert, Klaus Jung	2012	72
9	Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy Clinica Chimica Acta ·Zofia Wotschofsky, Jonas Busch, Monika Jung, Carsten Kempkensteffen, Steffen Weikert, K.-D. Schaser, I. Melcher, Ergin Kilic, Kurt Miller, Glen Kristiansen, Andreas Erbersdobler, Klaus Jung	2012	60
10	Selective Lymph Node Dissection for Castration-Resistant Prostate Cancer Urologia Internationalis ·Jonas Busch, Stefan Hinz, Carsten Kempkensteffen, 哲男中島, Luísa Valente Gotardo Lara Alves, Steffen Weikert, Kurt Miller, Ahmed Magheli	2012	6
11	Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC) World Journal of Urology ·D. Baumunk, Uta Reichelt, 幹子江平, Hans Krause, Jan Ebbing, Hannes Cash, Kurt Miller, Martin Schostak, Steffen Weikert	2012	33
12	Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors World Journal of Urology ·Steffen Weikert, Carsten Kempkensteffen, Jonas Busch, Manfred Johannsen, Viktor Grünwald, G.A.J. Rogers, Anne Flörcken, Jörg Westermann, Isabel María Jurado Navarrete, Kurt Miller, Ulrich Keilholz	2011	15
13	Metabolic profiling reveals key metabolic features of renal cell carcinoma Journal of Cellular and Molecular Medicine ·Gareth Catchpole, Alexander Platzer, Cornelia Weikert, Carsten Kempkensteffen, Manfred Johannsen, Hans Krause, Klaus Jung, Kurt Miller, Lothar Willmitzer, Joachim Selbig, Steffen Weikert	2009	98
14	Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment Journal of Clinical Oncology ·Jens Köllermann, Steffen Weikert, Martin Schostak, Carsten Kempkensteffen, K. Kleinschmidt, Thomas Rau, Klaus Pantel	2008	62
15	The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours International Journal of Andrology ·Carsten Kempkensteffen, Djenaro Barchelot Plata, JOANNA KWAŚNIEWSKA, Steffen Weikert, Stefan Hinz, Frank Christoph, Hans Krause, Martin Schostak, Kurt Miller, Mark Schrader	2007	20
16	Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value Journal of Cancer Research and Clinical Oncology ·Carsten Kempkensteffen, Stefan Hinz, Frank Christoph, Hans Krause, Ahmed Magheli, Mark Schrader, Martin Schostak, Kurt Miller, Steffen Weikert	2007	37
17	Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors Journal of Cancer Research and Clinical Oncology ·Carsten Kempkensteffen, Frank Christoph, Steffen Weikert, Hans Krause, Jens Köllermann, Martin Schostak, Kurt Miller, Mark Schrader	2006	15
18	Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance International Journal of Cancer ·Carsten Kempkensteffen, Stefan Hinz, Frank Christoph, Jens Köllermann, Hans Krause, Mark Schrader, Martin Schostak, Kurt Miller, Steffen Weikert	2006	27
19	Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer International Journal of Cancer ·Steffen Weikert, Hans Krause, Ingmar Wolff, Frank Christoph, Mark Schrader, Thomas Emrich, Kurt Miller, Markus Müller	2005	30
20	Rapid Ca2+-dependent NO-production from central nervous system cells in culture measured by NO-nitrite/ozone chemoluminescence Brain Research ·Steffen Weikert, Dorette Freyer, Markus Weih, Н. К. Исаев, Christina Busch, Show‐Jen Chiou, Dirk Megow, Ulrich Dirnagl	1997	39

About Steffen Weikert

Steffen Weikert is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Reproductive Medicine, Urology and Molecular Biology, having authored 81 papers that have together received 2.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (25 papers), Renal and related cancers (25 papers), Bladder and Urothelial Cancer Treatments (13 papers), Cancer Genomics and Diagnostics (12 papers), Epigenetics and DNA Methylation (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Testicular diseases and treatments (9 papers) and Cell death mechanisms and regulation (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Pulmonary and Respiratory Medicine (1.2k citations), Molecular Biology (1.9k citations), Oncology (483 citations) and Surgery (554 citations). Steffen Weikert has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Kurt Miller, Börje Ljungberg, Jung Eun Lee, Lambertus A. Kiemeney, Steven C. Campbell, Didier Jacqmin, Mark Schrader, Hans Krause, Carsten Kempkensteffen and Frank Christoph. Their work appears in journals such as Journal of Clinical Oncology, World Journal of Urology, Journal of Cancer Research and Clinical Oncology, European Urology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact